Neuroendoscopy Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 3.27 Billion |
| Market Size (2029) | USD 4.25 Billion |
| CAGR (2024 - 2029) | 5.37 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Neuroendoscopy Market Analysis
The Neuroendoscopy Market size is estimated at USD 3.27 billion in 2024, and is expected to reach USD 4.25 billion by 2029, growing at a CAGR of 5.37% during the forecast period (2024-2029).
The neuroendoscopes market has been moderately impacted by the COVID-19 pandemic. These devices are used for the treatment of conditions of the central nervous system. As elective surgeries have been postponed, neuroendoscopes have been less utilized than usual and thus suffer from less investment than usual as well. Even as elective procedures resume, it is likely that patients will not attend their delayed screening due to nervousness from the crisis. The neuroendoscopes market suffered from less demand throughout 2020, though revenue rose in 2021 as delayed elective procedures were completed, and vaccines helped patients feel safer about completing screenings.
Neuroendoscopy is performed using an endoscope on end to allow the neurosurgeon to navigate and access the tumor. In order to remove a tumor or take a sample of it (a biopsy), neurosurgeons attach special instruments to the endoscope, often an additional endoscope with forceps and scissors on end, as opposed to conventional open brain surgery, which requires more time for healing post-surgery and induces less pain. Also, neuroendoscopic procedures cause minimal scarring in patients. These benefits are being considered widely in the medical community, and therefore, these procedures are becoming more common worldwide. Hence, the benefits of neuroendoscopic surgery over conventional brain surgery are expected to drive the growth of the market. Other factors that will affect the growth of this market include the rising prevalence of neurological disorders and favorable government initiatives.
Neuroendoscopy Market Trends
This section covers the major market trends shaping the Neuroendoscopy Market according to our research experts:
The Rigid Neuroendoscope Segment is Expected to Show Better Growth in the Forecast Period
Flexible neuroendosocpes are optic instrument that transmits light and carries images back to the observer through flexible transparent fibers and is used to inspect and treat interior portions of the body. Several advantages associated with flexible neuroendoscopy are expected to drive the demand for flexible neuroendoscopes. One of the primary advantages of flexible neuroendoscopes is that their geometry is not fixed and can be paved along a curved trajectory. Flexible endoscopes provide visibility of the internal side of the organ, which generally cannot be seen with a normal view. According to the study titled, '' Efficacy analysis of flexible neuroendoscopy combined with dry-field techniques in the treatment of chronic subdural hematoma'', published in June 2019, a flexible endoscopy device was used for chronic subdural hematoma (CSDH). The study revealed that flexible neuroendoscopy was efficient in combination with dry-field techniques (DFTs) in the treatment of CSDH patients.
Furthermore, as per a study titled. 'New perspectives in the endoscopic treatment of brain purulent collections: targets, techniques, results in a case series, and overview of the literature', published in May 2020, showed that flexible endoscopy in the treatment of purulent intracranial infections was effective. Such studies are expected to support market growth. The presence of technologically advanced products in the market is further expected to accelerate the market growth. For instance, ''flexible video neuro endoscope'' developed by Karl Storz GmbH is used in the treatment of hydrocephalus. It is the only Food & Drug Administration-approved video neuroendoscopes. Such products are expected to impact market growth positively.
Therefore, with the above-mentioned factors, the market is expected to boost in this segment.
North America is Estimated to Dominate the Neuroendoscopy Market
North America currently dominates the market and is expected to continue the same trend. The neuroendoscopy market is mainly driven by factors such as rising government initiatives and the increasing prevalence of neurological disorders.
In the United States, the risk of being affected by a neurodegenerative disease is increasing dramatically, with the rising geriatric population, as per the National Institute of Environmental Health Sciences. This indicates that most Americans may be affected by neurodegenerative diseases in the coming decades. As per the data of the United States Census Bureau, in 2019, about 54 million Americans are aged 65 years and above. Furthermore, according to the Alzheimer's Association, more than 5.8 million Americans suffer from Alzheimer's disease as of 2020.
Furthermore, as per the analysis of 2020 by the Central Brain Tumor Registry of the United States, in 2013-2017, the incidence rate of brain tumors (malignant and non-malignant) was recorded to be about 23.79 cases per 100,000, with the total count of nearly 415,411 incident tumors. In addition, the rising preference of people toward minimally invasive surgery as it cause less post-operative pain is also expected to boost the demand for neuroendoscopes in the market studied. The increasing product approvals are also expected to thrive in the market in this region. For instance, in January 2021, the United States Food and Drug Administration approved Axonpen System designed by ClearMind Biomedical. It is a novel neuroendoscopes that is used in the visualization of intracranial tissue and fluids and the controlled aspiration of tissue and/or fluid during surgery. Thus, with the rising burden of neurological disorders along with the rising preference for minimally invasive surgeries and technological advancements with respect to new products, it is expected to contribute to market growth.
Neuroendoscopy Industry Overview
The global players in the neuroendoscopy market are Adeor Medical AG, B. Braun Melsungen AG, Clarus Medical, KARL STORZ SE & Co. KG, Machida Endoscope Co. Ltd, Schindler Endoskopie Technologie GmbH, and Tonglu Wanhe Medical Instrument Co. Ltd.
Neuroendoscopy Market Leaders
-
Adeor Medical AG
-
B. Braun Melsungen AG
-
Clarus Medical
-
KARL STORZ SE & Co. KG
-
Machida Endoscope Co., Ltd.
*Disclaimer: Major Players sorted in no particular order
Neuroendoscopy Market News
- In August 2021, ClearPoint Neuro Inc., a global therapy-enabling platform company providing navigation and delivery to the brain, entered a strategic and commercial partnership with the German-based surgical equipment leader Adeor Medical AG.
Neuroendoscopy Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Neurological Disorders
- 4.2.2 Benefits of Neuroendoscopic Surgery over Conventional Brain Surgery
- 4.2.3 Favorable Government Initiatives
-
4.3 Market Restraints
- 4.3.1 High Cost of the Procedures
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product
- 5.1.1 Rigid Neuroendoscopes
- 5.1.2 Flexible Neuroendoscopes
-
5.2 By Application
- 5.2.1 Transnasal Neuroendoscopy
- 5.2.2 Intraventricular Neuroendoscopy
- 5.2.3 Transcranial Neuroendoscopy
-
5.3 By Usability
- 5.3.1 Reusable Neuroendoscopes
- 5.3.2 Disposable Neuroendoscopes
-
5.4 By Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle-East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Adeor Medical AG
- 6.1.2 B. Braun Melsungen AG
- 6.1.3 Clarus Medical
- 6.1.4 KARL STORZ SE & Co. KG
- 6.1.5 Machida Endoscope Co. Ltd
- 6.1.6 Schindler Endoskopie Technologie GmbH
- 6.1.7 Tonglu Wanhe Medical Instrument Co. Ltd
- 6.1.8 Visionsense Corporation
- 6.1.9 Locamed Ltd
- 6.1.10 Ackermann Instrumente GmbH
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityNeuroendoscopy Industry Segmentation
As per the scope of the report, neuroendoscopy is a minimally invasive surgical procedure in which the neurosurgeon removes the tumor through small holes in the skull or through the mouth or nose. The neuroendoscopy market is segmented by product (rigid neuroendoscopes and flexible neuroendoscopes), application (transnasal neuroendoscopy, intraventricular neuroendoscopy, and transcranial neuroendoscopy), usability (reusable neuroendoscopes and disposable neuroendoscopes), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.
| By Product | Rigid Neuroendoscopes | |
| Flexible Neuroendoscopes | ||
| By Application | Transnasal Neuroendoscopy | |
| Intraventricular Neuroendoscopy | ||
| Transcranial Neuroendoscopy | ||
| By Usability | Reusable Neuroendoscopes | |
| Disposable Neuroendoscopes | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Neuroendoscopy Market Research FAQs
How big is the Neuroendoscopy Market?
The Neuroendoscopy Market size is expected to reach USD 3.27 billion in 2024 and grow at a CAGR of 5.37% to reach USD 4.25 billion by 2029.
What is the current Neuroendoscopy Market size?
In 2024, the Neuroendoscopy Market size is expected to reach USD 3.27 billion.
Who are the key players in Neuroendoscopy Market?
Adeor Medical AG, B. Braun Melsungen AG, Clarus Medical, KARL STORZ SE & Co. KG and Machida Endoscope Co., Ltd. are the major companies operating in the Neuroendoscopy Market.
Which is the fastest growing region in Neuroendoscopy Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Neuroendoscopy Market?
In 2024, the North America accounts for the largest market share in Neuroendoscopy Market.
What years does this Neuroendoscopy Market cover, and what was the market size in 2023?
In 2023, the Neuroendoscopy Market size was estimated at USD 3.10 billion. The report covers the Neuroendoscopy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Neuroendoscopy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Neuroendoscopy Industry Report
Statistics for the 2024 Neuroendoscopy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Neuroendoscopy analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
